E. Sheldon

发表

randomized , double-blind noninferiority study of quadrivalent live attenuated nfluenza vaccine in adults

J. Falloon, S. Block, F. Dubovsky, 2011 .

Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial.

R. K. Evans, R. Railkar, C. Beals, 2016, The Lancet. Infectious diseases.

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

Chong-Jen Yu, Wen-Yuan Lin, M. Peeters, 2013, BMC Infectious Diseases.

A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults.

N. Kitchin, K. Jansen, W. Gruber, 2016, Vaccine.

Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow‐fill‐seal device in adults: a randomized, active‐controlled study *

M. Rousculp, F. Dubovsky, Robert J. Jeanfreau, 2012, Influenza and other respiratory viruses.

A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant.

J. Falloon, M. Esser, F. Dubovsky, 2016, Vaccine.

Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study

M. Schwickart, Keunpyo Kim, E. Sheldon, 2016, Advances in Therapy.

Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine

Bidan Huang, J. Goldstein, E. Sheldon, 2002, American Journal of Gastroenterology.

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study.

W. J. Ramsey, T. Monath, C. Link, 2017, The Lancet. Infectious diseases.

A phase 1, randomized, open-label, active-controlled trial to assess the safety of a meningococcal serogroup B bivalent rLP2086 vaccine in healthy adults

John L. Perez, E. Sheldon, H. Schwartz, 2012, Human vaccines & immunotherapeutics.

In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 x 10(10) colony-forming units.

D. Sack, J. Lindow, K. Pierce, 2010, Vaccine.

Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response.

J. Treanor, Langzhou Song, David N. Taylor, 2012, Vaccine.

Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study.

R. Frenck, K. Jansen, W. Gruber, 2017, Vaccine.

Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial.

D. Vaughn, A. Madan, B. Innis, 2017, Vaccine.

Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial.

A. Madan, Jyoti Soni, Ping Li, 2017, Vaccine.

Safety and long-term humoral immune response in adults after vaccination with an H1N1 2009 pandemic influenza vaccine with or without AS03 adjuvant.

D. Vaughn, Ping Li, L. Fries, 2012, The Journal of infectious diseases.

Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.

D. Cooper, R. Frenck, K. Jansen, 2017, Vaccine.

Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.

Bidan Huang, J. Goldstein, E. Sheldon, 2002 .

Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients. A prospective, multicenter, open-label effectiveness trial.

F. Burch, C. Codding, E. Sheldon, 2004, Osteoarthritis and cartilage.

Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.

A. Mangione, C. Birbara, E. Sheldon, 2003, The journal of pain : official journal of the American Pain Society.

Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers.

T. Rudge, E. Bernton, R. Hopkins, 2013, Vaccine.

Correlation of Measures of Pain, Function, and Overall Response: Results Pooled From Two Identical Studies of Etoricoxib in Chronic Low Back Pain

S. Smugar, E. Sheldon, A. Tershakovec, 2008, Spine.

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials

M. Blatter, E. Sheldon, M. Reeves-Hoché, 2010, The Lancet.

Long-term efficacy and safety of lumiracoxib 100 mg: an open-label extension of a 13-week randomized controlled trial in patients with primary osteoarthritis of the knee.

A. Beaulieu, E. Sheldon, R. Rebuli, 2008, Clinical and experimental rheumatology.

Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib

J. Maldonado-Cocco, R. Fleischmann, V. Sloan, 2006, Clinical Rheumatology.

Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.

A. Beaulieu, V. Sloan, E. Sheldon, 2005, Clinical therapeutics.

Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults.

Gurdyal Kalsi, F. Hampel, R. Hopkins, 2016, Vaccine.

Phase 3 trial evaluating the immunogenicity and safety of a three-dose BioThrax® regimen for post-exposure prophylaxis in healthy adults.

R. Hopkins, E. Sheldon, Cynthia B Strout, 2014, Vaccine.

Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis

B. Galer, A. Gammaitoni, F. Burch, 2004, Current medical research and opinion.

Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial.

J. Boice, E. Sheldon, A. Reicin, 2005, Mayo Clinic proceedings.

Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint®) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial

D. Kalman, E. Sheldon, H. Schwartz, 2008, Nutrition Journal.

Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults.

J. Langley, Ping Li, L. Fries, 2010, The Journal of infectious diseases.

Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies

A. Rodgers, C. Birbara, G. Ruoff, 2006, Current medical research and opinion.

Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study

D. Vaughn, J. Langley, Ping Li, 2011, The Journal of infectious diseases.

Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.

A. Gammaitoni, A. Kivitz, E. Sheldon, 2008, Clinical therapeutics.

Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: results of a randomised single heterologous booster dose study at 15 months.

D. Vaughn, J. Langley, Ping Li, 2011, Vaccine.

Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: Results of a randomised single heterologous booster dose study at 15 months.

D. Vaughn, J. Langley, Ping Li, 2013, Vaccine.

D. Kalman, E. Sheldon, H. Schwartz, 2008, Nutrition Journal.

A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.

J. Falloon, S. Block, F. Dubovsky, 2011, Vaccine.

Nutrition Journal Effect of a Natural Extract of Chicken Combs with a High Content of Hyaluronic Acid (hyal-joint ® ) on Pain Relief and Quality of Life in Subjects with Knee Osteoarthritis: a Pilot Randomized Double-blind Placebo-controlled Trial

D. Kalman, E. Sheldon, H. Schwartz, 2022 .